VAERS reports by lot

Merck HPV lot 1745AA: VAERS reports

33 VAERS reports list lot 1745AA as a Merck HPV vaccine, received between 2012-04-03 and 2014-10-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
33%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2730%
General / Systemic (non-local)2022%
Cardiac / Cardiovascular1011%
Gastrointestinal89%
Dermatological (non-injection-site)89%
Musculoskeletal55%
Thrombotic / Hematological33%
Allergic / Anaphylactic33%
Respiratory33%
Psychiatric / Neuropsychiatric22%
Injection-site / Local reaction22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania3
New Jersey3
Rhode Island2
California2
Maryland2
Texas2
Oregon2
Nebraska1
Connecticut1
Florida1
Indiana1
Arkansas1

Reports by month received

2012-044
2012-052
2012-063
2012-073
2012-083
2012-095
2012-102
2012-112
2013-011
2013-101
2013-112
2014-011
2014-022
2014-041
2014-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.